Status:
COMPLETED
Extracorporeal Shock Wave Versus Local Corticosteroid Injection for Carpal Tunnel Syndrome
Lead Sponsor:
Chinese Medical Association
Conditions:
Carpal Tunnel Syndrome
Shock Wave
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
This RCT is to investigate the clinical effect of extracorporeal shock wave therapy (ESWT) compared to the local corticosteroid injection (LCI) in managing mild to moderate carpal tunnel syndrome (CTS...
Detailed Description
To investigate the effect of extracorporeal shock wave therapy (ESWT) compared to the local corticosteroid injection (LCI) in managing mild to moderate carpal tunnel syndrome (CTS). About 50-60 patien...
Eligibility Criteria
Inclusion
- The patients aged ≥18 years
- Should present a new episode of CTS with symptoms lasting for ≥ six weeks
- Symptoms include wrist pain, numbness, and paraesthesia on the hands
- Tested postive by the Phalen test and Tinel test
- Electrodiagnostically diagnosed with mild to moderate CTS
Exclusion
- A lack of consent information
- A history of a CTS surgery or LCI in the carpal tunnel
- Asystemic disease that may interfere with the study
Key Trial Info
Start Date :
April 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2020
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04767724
Start Date
April 10 2018
End Date
April 10 2020
Last Update
February 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ningbo Medical Center Lihuili Hospital
Ningbo, Zhejiang ZJ, China, 315000